Mucosal healing on endoscopy has emerged as a key prognostic parameter in the
management of patients with IBD (Crohn's disease, ulcerative colitis/UC) and can predict …

Endoscopic healing is recognized as a primary treatment goal in Inflammatory Bowel
Disease (IBD). However, endoscopic remission may not reflect histological remission, which …

Background Treatment targets of ulcerative colitis (UC) have evolved to include not only
endoscopic but also histologic remission. However, the concept of histological activity is still …

Abstract Background and Objectives In spite of rapid growth of artificial intelligence (AI) in
digestive endoscopy in lesion detection and characterization, the role of AI in inflammatory …

Significant advances in artificial intelligence (AI) over the past decade may potentially lead
to dramatic effects on clinical practice. Digitized histology represents an area ripe for AI …

Abstract Background and Aims Histological disease activity in inflammatory bowel disease
[IBD] is associated with clinical outcomes and is an important endpoint in drug development …

Integrating artificial intelligence into inflammatory bowel disease (IBD) has the potential to
revolutionise clinical practice and research. Artificial intelligence harnesses advanced …

Introduction Treatment goals for ulcerative colitis (UC) are evolving from the achievement of
clinical remission to more rigorous goals defined by endoscopic and histologic healing …

Endoscopy, histology, and cross-sectional imaging serve as fundamental pillars in the
detection, monitoring, and prognostication of inflammatory bowel disease (IBD). However …

Endoscopic remission is an important therapeutic goal in ulcerative colitis (UC). The
Ulcerative Colitis Endoscopic Index of Severity (UCEIS) and Mayo Endoscopic Score (MES) …